Equity Profile

SYK

Stryker Corporation

Health CareHealth Care Equipment$125.0B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Stryker Corporation (SYK) is a leading medical technology company that develops and manufactures innovative healthcare equipment. With a market cap of $127 billion, Stryker plays a crucial role in the health care sector, focusing on products that enhance patient care and improve surgical outcomes.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Not available

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, which is vital for long-term success.

Not available

Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q1-2026, Stryker reported an EPS of $2.60, falling short of expectations by 12.63%. The stock remained unchanged the following day, indicating investor caution.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Stryker's upcoming earnings are mixed, given the recent earnings miss and lack of analyst estimates. Investors are looking for signs of recovery and growth.

Bull Case

If Stryker can demonstrate strong revenue growth and improved margins, it could signal a rebound in demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company continues to miss earnings expectations or fails to provide a clear growth strategy, it may lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What specific revenue growth figures can Stryker provide for its key product lines?

Investors will closely watch for any signs of recovery in revenue, especially after the recent earnings miss, as this could impact future growth expectations.

Will management address the reasons behind the recent EPS miss and outline a clear strategy moving forward?

Understanding the management's strategy and addressing past performance will be crucial for investor confidence and stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Stryker's potential for recovery, as the company's innovative pipeline could drive unexpected growth.

Supporting Evidence

The recent earnings miss may be a temporary setback rather than a long-term trend.

Stryker's strong market position and product portfolio provide a solid foundation for future growth.

Key Risk

If Stryker can show signs of strong demand for its new products, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on Stryker's ability to demonstrate growth and recovery in a competitive healthcare market.

Bull Confirmed If

A revenue growth rate of at least 5% year-over-year would confirm the bull case.

Bear Confirmed If

If revenue growth is flat or negative, it would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±1.09%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a modest move of approximately 1.09%, suggesting that investors are uncertain about the upcoming earnings report.

Options are pricing ±1.1% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests a potential stock increase of around 0.75%, confirming a positive outlook.

In-Line / Cautious

If results are in line but cautious, the stock may see minimal movement as investors await further clarity.

Miss

Should the company miss again, history suggests a potential decline of around 0.00%, reflecting ongoing investor concerns.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management strategies and their effect on margins.
4Details on international sales performance and growth opportunities.
5Any changes in guidance for the upcoming quarters.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Not available

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and drive sales, which is vital for long-term success.

Not available

Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q1-2026, Stryker reported an EPS of $2.60, falling short of expectations by 12.63%. The stock remained unchanged the following day, indicating investor caution.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Stryker's upcoming earnings are mixed, given the recent earnings miss and lack of analyst estimates. Investors are looking for signs of recovery and growth.

Bull Case

If Stryker can demonstrate strong revenue growth and improved margins, it could signal a rebound in demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company continues to miss earnings expectations or fails to provide a clear growth strategy, it may lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What specific revenue growth figures can Stryker provide for its key product lines?

Investors will closely watch for any signs of recovery in revenue, especially after the recent earnings miss, as this could impact future growth expectations.

Will management address the reasons behind the recent EPS miss and outline a clear strategy moving forward?

Understanding the management's strategy and addressing past performance will be crucial for investor confidence and stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Stryker's potential for recovery, as the company's innovative pipeline could drive unexpected growth.

Supporting Evidence

The recent earnings miss may be a temporary setback rather than a long-term trend.

Stryker's strong market position and product portfolio provide a solid foundation for future growth.

Key Risk

If Stryker can show signs of strong demand for its new products, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on Stryker's ability to demonstrate growth and recovery in a competitive healthcare market.

Bull Confirmed If

A revenue growth rate of at least 5% year-over-year would confirm the bull case.

Bear Confirmed If

If revenue growth is flat or negative, it would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±1.09%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a modest move of approximately 1.09%, suggesting that investors are uncertain about the upcoming earnings report.

Options are pricing ±1.1% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests a potential stock increase of around 0.75%, confirming a positive outlook.

In-Line / Cautious

If results are in line but cautious, the stock may see minimal movement as investors await further clarity.

Miss

Should the company miss again, history suggests a potential decline of around 0.00%, reflecting ongoing investor concerns.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into cost management strategies and their effect on margins.
4Details on international sales performance and growth opportunities.
5Any changes in guidance for the upcoming quarters.